Use of at least two standard aspirin weekly, for 10 years or more, reduces colon cancer risk in women. Subject to certain caveats, aspirin should be considered for colon cancer prophylaxis.
Related Articles
Cutting Edge
The vitamin D question: what’s the best advice?
Past events
Rome (Italy), 25-26/11/2016 – Molecular Diagnostics, Genomics and Epigenetics in Clinical Oncology
Senza categoria